SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: NEWS RELEASE Skystar Bio-Pharmaceutical Reports Second Quarter 2011

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution and Sales Channels XI’AN, CHINA – August 23, 2011 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights · Revenue increases 10% YoY to $9.1 million · Veterinary vaccines totaled $0.4million, up 1.2% YoY · Veterinary]

By | 2016-03-01T05:06:23+00:00 August 23rd, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[NEWS RELEASEystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution andles Channels XIAN, CHINA August 23, 2011 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights Revenuereases 10% YoY to $9.1 million Veterinary vaccines totaled $0.4million, up 1.2% YoY]

By | 2016-02-05T03:30:22+00:00 August 23rd, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: NEWS RELEASEystar Bio-Pharmaceutical Reports Second Quarter 2011 Results

[NEWS RELEASEystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution andles Channels XIAN, CHINA August 23, 2011 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights Revenuereases 10% YoY to $9.1 million Veterinary vaccines totaled $0.4million, up 1.2% YoY]

By | 2016-02-05T03:31:00+00:00 August 23rd, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page No. 3 PART I. FINANCIAL INFORMATION 4 Item 1. Condensed Consolidated Financial Statements 4 Condensed Consolidated Balance Sheets as of June 30, 2011 (unaudited) and December 31, 2010 4 Condensed Consolidated Statements of Income and Other Comprehensive Income for the Six Months Ended June 30, 2011 and 2010 (unaudited) 5] [CERTIFICATION I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SKYSTAR BIO-PHARMACEUTICAL COMPANY; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SKYSTAR BIO-PHARMACEUTICAL COMPANY; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Weibing Lu] [CERTIFICATION (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Bing Mei Bing Mei Chief Financial Officer (Principal Accounting and Financial Officer)]

By | 2016-03-01T05:08:07+00:00 August 22nd, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of June 30, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements ofome and Othermprehensiveomefor the Six Months Ended June 30, 2011 and 2010 (unaudited)] [CERTIFICATION I, WeibingLu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. WeibingLu v233000_ex32-1.htm 4 EX-32.1] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Bing Mei Bing Mei Chief Financial Officer (Principal Accounting and Financial Officer) v233000_ex32-2.htm 5 EX-32.2]

By | 2016-02-05T03:33:09+00:00 August 22nd, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of June 30, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements ofome and Othermprehensiveomefor the Six Months Ended June 30, 2011 and 2010 (unaudited)] [CERTIFICATION I, WeibingLu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. WeibingLu v233000_ex32-1.htm 4 EX-32.1] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Bing Mei Bing Mei Chief Financial Officer (Principal Accounting and Financial Officer) v233000_ex32-2.htm 5 EX-32.2]

By | 2016-02-05T03:32:18+00:00 August 22nd, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-Q: (Original Filing)

[PART II -- RULES 12b-25(b) AND (c) ½ ½ ½ ½ ½ [ X ] ½ ½ ½ ½ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or]

By | 2016-03-01T05:11:38+00:00 August 16th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-Q: PART II — RULES 12b-25(b) AND (c) ½

[PART II -- RULES 12b-25(b) AND (c) ½ ½ ½ ½ ½ [ X ] ½ ½ ½ ½ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or]

By | 2016-03-01T05:12:24+00:00 August 16th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] NT 10-Q: (Original Filing)

[PART II -- RULES 12b-25(b) AND (c) [ X ] (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed]

By | 2016-02-05T03:33:47+00:00 August 16th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] NT 10-Q: PART II — RULES 12b-25(b) AND (c) [

[PART II -- RULES 12b-25(b) AND (c) [ X ] (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed]

By | 2016-02-05T03:34:36+00:00 August 16th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar